Menu
Busca un Especialista
Busca un Especialista

Notas al pie

    1. Feldman HA, Goldstein I, Hatzichristou DG, et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994 Jan;151(1):54-61.
    2. Erectile dysfunction. NIH: Instituto Nacional de la Diabetes y las Enfermedades Digestivas y Renales. http://www.nlm.nih.gov/medlineplus/erectiledysfunction.html. Fecha de acceso: mayo de 2015.
    3. DiMeo PJ. Psychosocial and relationship issues in men with erectile dysfunction. Urol Nurs. 2006 Dec;26(6):442-6.
    4. Phé V, Rouprêt M. Erectile dysfunction and diabetes: A review of the current evidence-based medicine and a synthesis of the main available therapies. Diabetes Metab. 2012 Feb;38(1):1-13.
    5. Shabsigh R, Lue TF. A Clinician’s Guide to disfunción eréctil Management. New York: Haymarket Media Inc.; 2006.
    6. Problemas sexuales y urológicos de la diabetes. NIH: Instituto Nacional de la Diabetes y las Enfermedades Digestivas y Renales. http://diabetes.niddk.nih.gov/dm/pubs/sup/. Fecha de acceso: mayo de 2015.
    7. Malavige LS, Levy JC. Erectile dysfunction in diabetes mellitus. J Sex Med. 2009 May;6(5):1232-47.
    8. Hatzimouratidis K, Hatzichristou D. How to treat erectile dysfunction in men with diabetes: from pathophysiology to treatment. Curr Diab Rep. 2014;14(11):545.
    9. Walsh TJ, Hotaling JM, Smith A, et al. Men with diabetes may require more aggressive treatment for erectile dysfunction. Int J Impot Res. 2014 May-Jun;26(3):112-5.
    10. Montorsi F, Rigatti P, Carmingnani G, et al. AMS three-piece inflatable implants for erectile dysfunction: a long-term multi-institution study in 200 consecutive patients. Eur Urol. 2000 Jan;37(1):50-5.
    11. Gandaglia G, Briganti A, Jackson G, et al. A systematic review of the association between erectile dysfunction and cardiovascular disease. Eur Urol. 2014 May;65(5):968-78.
    12. Böhm M, Baumhäkel M, Teo K, et al. Erectile dysfunction predicts cardiovascular events in high-risk patients receiving Telmisartan, Ramipril, or both: The ongoing Telmisartan alone and in combination with Ramipril global endpoint trial/Telmisartan randomized assessment study in ACE intolerant subjects with cardiovascular disease (ONTARGET/TRANSCEND) trials. Circulation. 2010 Mar 30;121(12):1439-46.
    13. Jackson G, Rosen RC, Kloner RA, et al. The second Princeton consensus on sexual dysfunction and cardiac risk: new guidelines for sexual medicine. J Sex Med. 2006 Jan;3(1):28–36.
    14. Haglind E, Carlsson S, Stranne J, et al. Urinary incontinence and erectile dysfunction after robotic versus open radical prostatectomy: a prospective controlled nonrandomized trial. Eur Urol. 2015 Aug;68(2):216-25.
    15. Wittmann D, Carolan M, Given B, et al. What couples say about their recovery of sexual intimacy after prostatectomy: toward the development of a conceptual model of couples’ sexual recovery after surgery for prostate cancer. J Sex Med. 2015 Feb;12(2):494-504.
    16. Mulhall JP, Bivalacqua TJ, Becher EF. Standard operating procedure for the preservation of erectile function outcomes after radical prostatectomy. J Sex Med. 2013 Jan;10(1):195-203.
    17. Información de prescripción de Viagra™. Pfizer, Inc. Revisado en enero de 2010.
    18. Información de prescripción de Cialis™. Lily USA, LLC. Revisado en octubre de 2011.
    19. Información de prescripción de Levitra™. Bayer HealthCare Pharmaceuticals. Revisado en noviembre de 2011.
    20. Guía del usuario del sistema de terapia de vacío Osbon ErecAid™ Esteem™. Timm Medical Technologies, Inc. 2011.
    21. Hellstrom WJ, Montague DK, Moncada I, et al. Implants, mechanical devices, and vascular surgery for erectile dysfunction. J Sex Med. 2010 Jan;7(1 Pt 2):501-23.
    22. Información de prescripción de Caverject™. Pharmacia & Upjohn Company. Revisado en marzo de 2014.
    23. Brant WO, Bella AJ, Lue TF. Treatment options for erectile dysfunction. Endocrinol Metab Clin North Am. 2007 Jun;36(2):465-79.
    24. Información de prescripción de MUSE™. Meda Pharmaceuticals, Inc. Revisado en marzo de 2011.
    25. Instrucciones de uso de la línea de productos de prótesis de pene AMS 700™ con MS Pump™ American Medical Systems, Inc. 2016.
    26. GoodRx. Ejemplo de ahorros con GoodRx. http://www.goodrx.com/. Fecha de acceso: mayo de 2015.
    27. Matthew AG, Goldman A, Trachtenberg J, et al. Sexual dysfunction after radical prostatectomy: prevalence, treatments, restricted use of treatments and distress. J Urol. 2005 Dec;174(6):2105-10.
    28. Scott FB, Bradley WE, Timm GW. Management of erectile impotence: use of implantable inflatable prosthesis. Urology. 1973 Jul:2(1):80-2.
    29. Levine LA, Estrada CR, Morgentaler A. Mechanical reliability and safety of, and patient satisfaction with the Ambicor inflatable penile prosthesis: results of a 2 center study. J Urol. 2001 Sep;166(3):932-7.
    30. Bernal RM, Henry GD. Contemporary patient satisfaction rates for three-piece inflatable penile prostheses. Adv Urol. 2012;2012:707321.
    31. Datos en archivo en Boston Scientific.
    32. FDA/PDP N970012-S065.
    33. Con base en el límite del deducible de Medicare 2015 de $1260 para pacientes sometidos a un procedimiento ambulatorio. El máximo promedio estimado de gastos de bolsillo para un paciente con seguro comercial es de $3,664 ($750-10,000). Los planes Medicare Advantage y los planes de seguro privado varían en deducibles y coseguros.
    34. Datos en archivo en Boston Scientific.
    35. AMS 700™ Patient Manual. Información e instrucciones para pacientes que consideran una prótesis de pene inflable. American Medical Systems, Inc. 2016.
    36. Catalona WJ. Conditions after a Radical Prostatectomy. Urological Research Foundation. http://www.drcatalona.com/qa/faq_rp-conditions.asp. Fecha de acceso: mayo de 2015.
    37. Enemchukwu EA, Kaufman MR, Whittam BM, et al. Comparative revision rates of inflatable penile prosthesis using woven Dacron® fabric cylinders. J Urol. 2013 Dec;190(6):2189-93.
    38. Carson CC III, Mulcahy JJ, Harsch MR. Long-term infection outcomes after original antibiotic impregnated inflatable penile prosthesis implant: up to 7.7 years of follow-up. J Urol. 2011 Feb;185(2):614-8.
    39. Instrucciones de uso de la prótesis de pene ocultable Spectra™. American Medical Systems, Inc. 2017.
    40. Información de prescripción de Stendra™. Vivus, Inc. 2014.
    41. Selvin E, Burnett AL, Platz EA. Prevalence and risk factors for erectile dysfunction in the US. Am J Med. 2007 Feb;120(2):151-7.
    42. Disfunción eréctil (disfunción eréctil). Asociación Americana de Urología. Descargado el 27 de marzo de 2019.
    43. Catalona WJ. Sexual Potency after a Radical Prostatectomy. Urological Research Foundation. http://www.drcatalona.com/qa/faq_rp-potency.asp. Fecha de acceso: mayo de 2015.
    44. Penile Implants-Erectile Dysfunction. Sex Health Matters: http://www.sexhealthmatters.org/erectile-dysfunction/penile-implants-erectile-dysfunction/P7. Consultado el 3 de diciembre de 2014.
    45. Disfunción eréctil (disfunción eréctil). Asociación Americana de Urología. www.auanet.org/content/education-and-meetings/med-stu-curriculum/ed.pdf. Fecha de acceso: 21 de enero de 2013.
    46. Datos en archivo en Boston Scientific.
    47. Kloner R. Erectile dysfunction in the cardiac patient. Curr Urol Rep. 2003 Dec;4(6):466-71.
    48. Rajpurkar A, Dhabuwala CB. Comparison of satisfaction rates and erectile function in patients treated with sildenafil, intracavernous prostaglandin E1 and penile implant surgery for erectile dysfunction in urology practice. J Urol. 2003 Jul;170(1):159-63.
    49. Padma-Nathan H, Hellstrom WJ, Kaiser FE, et al. Treatment of men with erectile dysfunction with transurethral alprostadil. Medicated Urethral System for Erection (MUSE) Study Group. N Engl J Med. 1997 Jan 2;336(1):1-7.
    50. Costabile RA, Spevak M, Fishman IJ, et al. Efficacy and safety of transurethral alprostadil in patients with erectile dysfunction following radical prostatectomy. J Urol. 1998 Oct;160(4):1325-8.
    51. Sung HH, Ahn JS, Kim JJ, et al. The role of intracavernosal injection therapy and the reasons of withdrawal from therapy in patients with erectile dysfunction in the era of PDE5 inhibitors. Andrology. 2014 Jan;2(1):45-50.
    52. Ishii N, Watanabe H, Irisawa C, et al. Intracavernous injection of prostaglandin E1 for the treatment of erectile impotence. J Urol. 1989 Feb;141(2):323-5.
    53. Defade BP, Carson CC 3rd, Kennelly MJ. Postprostatectomy erectile dysfunction: the role of penile rehabilitation. Rev Urol. 2011;13(1): 6-13.
    54. WebMD. Erectile Dysfunction Health Center Slide Show: A Visual Guide to Erectile Dysfunction. http://www.webmd.com/erectile-dysfunction/ss/slideshow-erectile-dysfunction. Fecha de acceso: 23 de marzo de 2016.
    55. Cappelleri JC, Rosen RC. The Sexual Health Inventory for Men (SHIM): a 5-year review of research and clinical experience. Int J Impot Res. 2005 Jul-Aug;17(4):307-19.
    56. Miner MM, Kuritzky L. Erectile dysfunction: a sentinel marker for cardiovascular disease in primary care. Cleve Clin J Med. 2007 May;74 Suppl 3:S30-7. Revisión.
    57. Thompson IM, Tangen CM, Goodman PJ, et al. Erectile dysfunction and subsequent cardiovascular disease. JAMA. 2005 Dec 21;294(23):2996-3002.
    58. Montorsi P, Roumeguere T, Montosri F, et al. Is there a link between erectile dysfunction and cardiovascular disease? EAU Update Series 2. 2004 Jun:2;43-8.
    59. Nehra A, Jackson G, Miner M, et al. The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clin Proc. 2012 Aug;87(8):766-78.
    60. Asociación Americana de la Diabetes. Hoja informativa 2015. http://main.diabetes.org/dorg.adm.adm-2015-fact-sheet. Fecha de acceso: 22 de marzo de 2016.
    61. Jackson G, Boon N, Eardley I, et al. Erectile dysfunction and coronary artery disease prediction: evidence-based guidance and consensus. Int J Clin Pract. 2010 Jun;64(7):848-57.
    62. World Cancer Research Fund International. https://www.wcrf.org. Fecha de acceso: 4 de febrero de 2015.
    63. Catalona WJ. Conditions after a Radical Prostatectomy. Urological Research Foundation. http://www.drcatalona.com/qa/faq_rp-conditions.asp. Fecha de acceso: mayo de 2015.
    64. Frederick DA, Lever J, Gillespie BJ, et al. What keeps passion alive? Sexual satisfaction is associated with sexual communication, mood setting, sexual variety, oral sex, orgasm, and sex frequency in a national U.S. study. J Sex Res. 2017 Feb;54(2):186-201.
    65. Smith IA, McLeod N, Rashid P. Erectile dysfunction when tablets don’t work. Aust Fam Physician. 2010 May;39(5):301-5. Revisión.
    66. WebMD. Getting Intimate: Talking Together About disfunción eréctil. http://www.webmd.com/erectile-dysfunction/features/getting-intimate-talking-together-about-ed. Fecha de acceso: 31 de marzo de 2016.
    67. Wittmann D, Carolan M, Given B, et al. Exploring the role of the partner in couples’ sexual recovery after surgery for prostate cancer. Support Care Cancer. 2014 Sep;22(9):2509-15.
    68. Kerfoot WW, Carson CC. Pharmacologically induced erection among geriatric men. J Urol. 1991 Oct;146(4):1022-4.
    69. Mydlo JH, Volpe MA, MacChia RJ. Results from different patient populations using combined therapy with alprostadil and sildenafil: predictors of satisfaction. BJU Int. 2000 Sep;86(4):469-73.
    70. Levine LA, Becher E, Bella A, et. al. Penile Prosthesis Surgery: Current recommendations From the International Consultation on Sexual Medicine. J Sex Med. 2016 Apr;13(4):489-518.
    71. Solomon H, Man JW, Jackson G. Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator. Heart 2003;89(3):251-3.
    72. Oakley N, Moore KT. Vacuum devices in erectile dysfunction: indications and efficacy. Br J Urol. 1998 Nov;82(5):673-81.
    73. Saigal CS, Wessells H, Pace J, et al; Urologic DIAP. Predictors and Prevalence of erectile dysfunction in a racially diverse population. Arch Intern Med. 2006 Jan;166(2):207–12.
    74. Manual para pacientes de la prótesis de pene maleable Tactra™. Información e instrucciones para pacientes que consideran una prótesis de pene maleable Tactra. Boston Scientific. 2018.
    75. Instrucciones de uso del implante de pene maleable Tactra™. Boston Scientific 2018.
    76. WebMD. Erectile Dysfunction: Penile Prosthesis. https://www.webmd.com/erectile-dysfunction/guide/penile-prosthesis. Fecha de acceso: 16 de septiembre de 2019.
    77. Surgeo.com. Penile Implant. https://surgeo.com/compare?package[]=469&package[]=844 Accessed October 28, 2019.
    78. Datos en archivo en Boston Scientific y basados en estudios de mercado de Northstar.
    79. Archivos del censo de los Estados Unidos. Estimaciones anuales de la población residente para grupos de edad seleccionados por sexo para los Estados Unidos, estados, condados y el Estado Libre Asociado y Municipios de Puerto Rico: 2018.
    80. Selvin E, Burnett AL, and Platz EA. Prevalence and Risk Factors for Erectile Dysfunction in the US. Am J Med. 2007: 120(2): 153.

    81. Mazur DJ, Gondokusumo JC, McBride JA, Pastuszak AW, Lipshultz LI. PD18-03 Doomed to Impotence: Analysis of Erectile Dysfunction (disfunción eréctil) and Inflatable Penile Prosthesis (IPP) Insurance Coverage From Verification Benefits Databases. The Journal of Urology. 2018 Apr 30;199(4): e390.

    82. Sellers T, Dineen M, Salem E, et al. Vacuum preparation, optimization of cylinder length and postoperative daily inflation reduces complaints of shortened penile length following implantation of inflatable penile prosthesis. Adv in Sex Med. 2013 Jan;3(91):14-8.

    83. Kamel I, Gadalla A, Ghanem H, et al. Comparing penile measurements in normal and erectile dysfunction subjects. J Sex Med. 2009 Aug;6(8):2305-10.

    84. Manual para el quirófano de la prótesis de pene AMS 700™ con MS Pump™. American Medical Systems. 2018.

    85. Salem EA, Wilson SK, Neeb A, et al. Mechanical reliability of AMS 700 CX improved by parylene coating. J Sex Med. 2009 Sep;6(9):2615-20.